Red Spruce Capital’s Idexx Laboratories IDXX Stock Holding History

Red Spruce Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827K	Hold	1,571	–	–	0.29%	70
2026 Q1	$883K	Hold	1,571	–	–	0.36%	65
2025 Q4	$1.06M	Sell	1,571 -13	-0.8%	-$8.85K	0.42%	64
2025 Q3	$1.01M	Sell	1,584 -117	-7%	-$71K	0.41%	64
2025 Q2	$912K	Buy	1,701 +19	+1%	+$9.09K	0.4%	66
2025 Q1	$706K	Sell	1,682 -82	-5%	-$35.6K	0.33%	72
2024 Q4	$729K	Sell	1,764 -168	-9%	-$73.7K	0.32%	71
2024 Q3	$976K	Buy	1,932 +40	+2%	+$19.4K	0.44%	64
2024 Q2	$922K	Buy	1,892 +126	+7%	+$63.3K	0.43%	65
2024 Q1	$954K	Hold	1,766	–	–	0.44%	67
2023 Q4	$980K	Sell	1,766 -15	-0.8%	-$7.04K	0.5%	64
2023 Q3	$779K	Sell	1,781 -17	-0.9%	-$8.48K	0.44%	65
2023 Q2	$903K	Sell	1,798 -176	-9%	-$84.3K	0.49%	64
2023 Q1	$987K	Buy	1,974 +10	+0.5%	+$4.79K	0.58%	59
2022 Q4	$801K	Hold	1,964	–	–	0.51%	60
2022 Q3	$640K	Buy	1,964 +27	+1%	+$9.92K	0.45%	64
2022 Q2	$679K	Buy	1,937 +32	+2%	+$13K	0.45%	64
2022 Q1	$1.04M	Buy	1,905 +133	+8%	+$70K	0.59%	55
2021 Q4	$1.17M	Sell	1,772 -103	-5%	-$64.7K	0.64%	54
2021 Q3	$1.17M	Buy	1,875 +6	+0.3%	+$4.03K	0.68%	55
2021 Q2	$1.18M	Buy	1,869 +13	+0.7%	+$7.18K	0.7%	53
2021 Q1	$908K	Sell	1,856 -45	-2%	-$22.5K	0.58%	57
2020 Q4	$950K	Buy	1,901 +26	+1%	+$11.6K	0.66%	54
2020 Q3	$737K	Hold	1,875	–	–	0.6%	55
2020 Q2	$619K	Sell	1,875 -26	-1%	-$7.53K	0.53%	59
2020 Q1	$460K	Sell	1,901 -97	-5%	-$25.3K	0.48%	64
2019 Q4	$522K	Buy	+1,998	New	+$527K	0.44%	63

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

SBWIC

Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.5B AUM 31.02% 1-Year Est. Return

Red Spruce Capital's IDXX Position: Q2 2026 in Review

Red Spruce Capital held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,571 shares worth $827K. The position accounts for 0.29% of the portfolio, ranked #70.

Red Spruce Capital first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.18M in Q2 2021. 235 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Red Spruce Capital held 1,571 shares of Idexx Laboratories worth $827K as of Q2 2026.
Red Spruce Capital left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.29% of Red Spruce Capital's portfolio in Q2 2026, its #70 holding.
Red Spruce Capital first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
Red Spruce Capital's Idexx Laboratories position peaked at $1.18M in Q2 2021.
235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Red Spruce Capital's 13F filing for Q2 2026, filed 7 Jul 2026.